THC Biomed Intl Ltd.
THC
CNSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 6.18% | -195.46% | 77.32% | -960.97% | 91.52% |
| Total Depreciation and Amortization | -10.43% | -0.82% | -48.60% | 427.72% | -68.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.64% | 201.66% | -81.60% | 241.86% | -133.92% |
| Change in Net Operating Assets | 55.00% | 291.70% | -208.11% | 488.72% | -197.99% |
| Cash from Operations | 203.61% | 84.20% | 17.00% | 44.90% | -240.41% |
| Capital Expenditure | 99.43% | -17,500.00% | 99.76% | 0.08% | 44.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -93.09% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.00% | -369.89% | 124.11% | -- | -- |
| Cash from Investing | 39.47% | -665.32% | 135.74% | -102.38% | 1,020.87% |
| Total Debt Issued | 23.25% | -- | -- | 856.42% | -59.16% |
| Total Debt Repaid | 9.16% | -0.28% | 91.96% | 7.21% | -1,397.99% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 58.56% | 189.04% | 69.69% | 74.73% | -870.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 249.36% | 76.96% | 54.48% | -184.92% | 408.59% |